EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Prognostic Significance of the CRP-Albumin-Lymphocyte Index (CALLY) in Triple Negative Breast Cancer Patients: A Real-World Retrospective Study

Yu Liu iD, Fuquan Zhang, Chunli Guo, Qi Li iD

Breast Cancer: Targets and Therapy · 2026-03 · Volume 18 · 1-19

DOI: 10.2147/bctt.s582022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Cancer: Targets and Therapy, 2026-03. Verfasst von Yu Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Tianjin Third Central Hospital; the Third Central Clinical College of Tianjin Medical University; Nankai University Af…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aims to explore the prognostic utility of the CRP-Albumin- Lymphocyte Index (CALLY) in triple-negative breast cancer (TNBC) patients undergoing curative resection.

Methods

A retrospective analysis of 172 TNBC patients treated surgically between January 2011 and December 2020 was conducted. Preoperative CALLY was calculated as (albumin × lymphocyte) / CRP Survival curves for disease free survival (DFS) and overall survival (OS) were estimated using Kaplan-Meier method, and differences between groups were statistically evaluated by Log rank test. Univariate and multivariate Cox proportional hazards regression model were constructed incorporating variables identified as potential independent variables. Nomograms were established according to the multivariate analysis results, and with internal validation performed using the consistency index (C-index), calibration curve, and decision curve analyses (DCA).

Results

Patients were stratified into low CALLY group (< 0.44, n=83) and high CALLY group (≥ 0.44, n=89) based on the optimal cutoff value of CALLY determined by receiver operating characteristic curve (ROC) analysis. High CALLY correlated with significantly prolonged DFS (32.54 vs. 28.97 months; χ 2 =14.070, P=0.0002) and OS (59.87 vs. 45.20 months; χ 2 =17.800, P< 0.0001). Multivariate regression analysis revealed that CALLY as an independent predictor of DFS (hazard ratio [HR]: 0.275, 95% confidence interval [CI]: 0.140– 0.539, P< 0.001) and OS (HR: 0.372, 95% CI: 0.182– 0.764, P = 0.007). Nomograms integrating CALLY, TOP2A, and postoperative chemotherapy demonstrated robust predictive accuracy for DFS (C-index: 0.717, 95% CI 0.595– 0.814) and OS (C-index: 0.725, 95% CI 0.605– 0.819).

Conclusion

CALLY reflects systemic inflammation, nutrition, and immune status, and represents a novel prognostic index for TNBC. Its integration into nomograms enhances personalized risk stratification and treatment decision-making. Keywords: triple negative breast cancer, CRP-Albumin-Lymphocyte Index, TOP2A, chemotherapy, survival

Schlagwörter

Stichwörter der Autor:innen

CRP-Albumin-Lymphocyte IndexTOP2Achemotherapysurvivaltriple negative breast cancer

Autor:innen und Institutionen

  • Department of General Surgery, Tianjin Third Central Hospital; the Third Central Clinical College of Tianjin Medical University; Nankai University Affinity the Third Central Hospital, Tianjin, 300170, People's Republic…

ORCID-Profile: Yu Liu, Qi Li

Zitieren

APA

Liu, Y., Zhang, F., Guo, C., & Li, Q. (2026). Prognostic Significance of the CRP-Albumin-Lymphocyte Index (CALLY) in Triple Negative Breast Cancer Patients: A Real-World Retrospective Study. Breast Cancer: Targets and Therapy, Volume 18, 1-19. https://doi.org/10.2147/bctt.s582022

Vancouver

Liu Y, Zhang F, Guo C, Li Q. Prognostic Significance of the CRP-Albumin-Lymphocyte Index (CALLY) in Triple Negative Breast Cancer Patients: A Real-World Retrospective Study. Breast Cancer: Targets and Therapy. 2026;Volume 18:1-19. doi:10.2147/bctt.s582022

BibTeX
@article{Liu2026,
  author = {Liu, Yu and Zhang, Fuquan and Guo, Chunli and Li, Qi},
  title = {Prognostic Significance of the CRP-Albumin-Lymphocyte Index (CALLY) in Triple Negative Breast Cancer Patients: A Real-World Retrospective Study},
  journal = {Breast Cancer: Targets and Therapy},
  year = {2026},
  volume = {Volume 18},
  pages = {1--19},
  doi = {10.2147/bctt.s582022}
}
Kostenlos starten →